Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Knight Therapeutics Inc. T.GUD

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic

Knight Therapeutics Inc, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets.
Price: $9.45 | Change: $-0.48 | %Change: -4.83%
Volume: 742,567 | Day High/Low: 10.00/9.45 | 52 Week High/Low: 9.96/3.51
View modes: 
0 stars

lowriskinvestor

Do you have access to some privelaged information? Because Knight' vision statement does refer to deleivering FDA vouchers on a regular basis it is explicit as Knight Therapeutics Inc, is a specialty...read more
3 stars

reference to FDA voucher

I was referring to the "possibility" of a new FDA voucher in the works ...not the one sold to Gilead in Nov 2014  rate and reply
0 stars

where's the news???

expecting news in short order. deals must me underway...they've already shown the deals exist. Goodman said they just need to turn the taps on...and...here we go. Bring it on! Trying to get...read more
0 stars

RE:RE:RE:Price Drop

You mean this one that they sold in November?  The only one they owned that I am aware of. Knight Sells Priority Review Voucher to Gilead MONTREAL, QUEBEC--(Marketwired – Nov. 19, 2014...read more
0 stars

RE:RE:RE:Price Drop

The Priority Review voucher was sold to Gilead for $125 million back in November, not sure when the deal closed though.  rate and reply
0 stars

RE:RE:Price Drop

The FDA voucher that they are selling  rate and reply
0 stars

RE:Price Drop

What voucher are you talking about?  rate and reply
5 stars

RE:Price Drop

Peaked at $10 today, an important psychological figure as well.   I wouldn't mind a nice healthy pullback, gives those who missed the boat a chance to buy and current holders to buy more at cheaper...read more
1 star

Price Drop

The selling this AM is healthy after such a rapid run-up.  The drop no doubt tripped stop-loss selling.  The upward momentum of the stock for the past 60 days may be reflecting Q4 results (due mid...read more
0 stars

Someone finally decided to take profits...

Been a while...someone finally pulled the trigger and offloaded some. Down 30 cents. Will it continue down or will it rebound by day's end????  rate and reply
1 star

RE:What is the consencious out there?

I recently sold my small stake in NRI, at a loss. Not worth my time and money, better deployed elsewhere. Management makes mistake after mistake.....and then gives themselves a bonus. I've seen the...read more
3.5 stars

RE:What is the consencious out there?

This question came up a few times over the past year and I am sticking to my original comments. Goodman has had a long standing relationship with them.  He never pulled the trigger while running...read more
5 stars

What is the consencious out there?

I am a fairly recent shareholder in Knight, but am also a long time shareholder in Nuvo Research(NRI.TO) What is the consencious out there for Knight to aggresively take over Nuvo? Nuvo recently...read more
5 stars

Paladin 2.0 ... bring home Mark Beaudet 1.0

Here it is guys...enjoy! It is entirely the goal of Knight Therapeutics (TSX:GUD) to duplicate the success of Paladin Labs,” says president and CEO, Jonathan Ross Goodman, who turned Paladin into...read more
0 stars

RE:RE:RE:Selling

Odds are that you are correct, I knew there was some sort of reference.  rate and reply
0 stars

RE:RE:Selling

I think you may be refering to the Q3 Results where he said "We are making GUD progress on becoming a Paladin 2.0."  rate and reply
0 stars

RE:Selling

I think I read somewhere sometime back that Mr. Goodman said He wanted GUD to be a Palladin #2 and not to take as long to develop.  rate and reply
5 stars

RE:RE:Grabbed some shares last week

Hey CommonCents, take it easy on your bum.  A couple of years from now it really will not matter that much if you got in at seven or nine.  In the past I have worked for average management and...read more
0 stars

Will Knight Correct on Earnings?

I do not think that current earnings or recurring revenue will support the current price.  Just my guess.  But then again Goodman is worshiped as a Saviour so it might not matter what earnings are now...read more
0 stars

Selling

This stock should be bought for a long term hold (5 year horizon); accumulate on weakness; never sell! CEO of GUD will build this into a new version of Paladin Labs!  rate and reply